1. Home
  2. STKS vs PMVP Comparison

STKS vs PMVP Comparison

Compare STKS & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The ONE Group Hospitality Inc.

STKS

The ONE Group Hospitality Inc.

HOLD

Current Price

$1.83

Market Cap

58.4M

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.26

Market Cap

66.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKS
PMVP
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
66.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
STKS
PMVP
Price
$1.83
$1.26
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.70
N/A
AVG Volume (30 Days)
16.4K
298.6K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,722,000.00
N/A
Revenue This Year
$7.47
N/A
Revenue Next Year
$8.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.66
N/A
52 Week Low
$1.65
$1.02
52 Week High
$3.38
$1.88

Technical Indicators

Market Signals
Indicator
STKS
PMVP
Relative Strength Index (RSI) 52.99 52.66
Support Level $1.69 $1.04
Resistance Level $1.97 $1.26
Average True Range (ATR) 0.09 0.07
MACD 0.01 0.01
Stochastic Oscillator 77.27 70.69

Price Performance

Historical Comparison
STKS
PMVP

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: